dc.contributor.author | Saip, Pinar | |
dc.contributor.author | Ozgur, Emre | |
dc.contributor.author | Sen, Fatma | |
dc.contributor.author | Gezer, Ugur | |
dc.contributor.author | Ferhatoglu, Ferhat | |
dc.date.accessioned | 2021-03-04T11:09:20Z | |
dc.date.available | 2021-03-04T11:09:20Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Ozgur E., Ferhatoglu F., Sen F., Saip P., Gezer U., "Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer", CANCER BIOMARKERS, cilt.27, sa.1, ss.11-17, 2020 | |
dc.identifier.issn | 1574-0153 | |
dc.identifier.other | av_70dda9b7-fc4f-4cee-b17c-9ae93b9e6459 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/77784 | |
dc.identifier.uri | https://doi.org/10.3233/cbm-190085 | |
dc.description.abstract | BACKGROUND: Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC). | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer | |
dc.type | Makale | |
dc.relation.journal | CANCER BIOMARKERS | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 27 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 11 | |
dc.identifier.endpage | 17 | |
dc.contributor.firstauthorID | 63984 | |